Generation and characterization of induced pluripotent stem cells from a Parkinson’s disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations
Stem Cell Research, ISSN: 1873-5061, Vol: 72, Page: 103212
2023
- 16Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures16
- Readers16
- 16
- Mentions1
- News Mentions1
- 1
Most Recent News
Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.
Stem Cell Res. 2023 Sep 28;72:103212. Authors: Oleksy C, Massart F, Goldwurm S, Arado A, Arena G, Boussaad I, Krüger R PubMed: 37832355 Submit Comment
Article Description
We describe an induced pluripotent stem cell (iPSC) line that was derived from fibroblasts obtained from a Parkinson’s disease (PD) patient carrying the p.G2019S mutation in the LRRK2 gene and the p.N409S mutation in the GBA1 gene. iPSCs were generated via Sendai virus transduction of Yamanaka factors. The presence of GBA1 p.N409S and LRRK2 p. G2019S was confirmed by Sanger sequencing. The iPSCs express pluripotency markers, are capable of in vitro differentiation into the three germ layers and have a normal karyotype. The newly generated line will be used for in vitro PD modeling by investigating the role of each mutation in iPSC-derived dopaminergic neurons.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1873506123001988; http://dx.doi.org/10.1016/j.scr.2023.103212; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85173821123&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37832355; https://linkinghub.elsevier.com/retrieve/pii/S1873506123001988; https://dx.doi.org/10.1016/j.scr.2023.103212
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know